-
Mashup Score: 11S2210 | SWOG - 2 month(s) ago
1. Disease Related Criteria Participant must have histologic diagnosis of prostate adenocarcinoma.Participant must have high or very high-risk disease defined by at least one of the following:cT3a to cT4xGrade Group 4 or 5 (Gleason sum 8-10)PSA > 20 ng/mL prior to registration Participant must have documented evidence of germline mutation (pathogenic/likely pathogenic variant) in BRCA2 or BRCA1…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 21Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 3 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Hope ... Springs Eternal | SWOG - 3 month(s) ago
Continuing that noble tradition, the newest Hope program is the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention, which will sponsor a speaker every year at our spring group meeting. Gary Goodman, MD, has been selected as the first Meyskens Lecturer. Dr. Goodman seems an ideal choice.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our @SWOGChair blog: Hope ... Springs Eternal The Hope Foundation for Cancer Research (@SupportingSWOG) is continuously developing new ways to support @SWOG strategic priorities for advancing #CancerResearch & improving patients' lives. Here are the latest https://t.co/S5QUJMXizm https://t.co/Cs8KnypF4e
-
-
Mashup Score: 2Targeting ATR in patients with cancer - 3 month(s) ago
Nature Reviews Clinical Oncology – Ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR) is a mediator of the cellular replication stress response that, upon activation,…
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 21Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 3 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 3 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG - 3 month(s) ago
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of spreading or coming back. Researchers want to find out if the chemotherapy drug carboplatin can help get rid of this type of cancer when it is given before surgery. The trial is for people…
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16S2207 | SWOG - 3 month(s) ago
Disease Related Criteria a. Participants must have: – Histologically confirmed relapsed/refractory LBCL as outlined by the World Health Organization (WHO) guidelines, classified as one of the following: – Large B-cell lymphoma, GBC and non-GCB types – Follicular lymphoma, grade 3B – Transformed lymphoma – High grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangementsb….
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Data Capture with nCartes: A Leap Day Opportunity | SWOG - 3 month(s) ago
For more than a decade, SWOG has been working to find a way for sites to access these EHR data more efficiently, while also improving data quality. In May of 2022, I wrote of our pilot project with cloud software provider nCartes, Inc., developing and implementing an EHR-to-EDC solution to make this data transfer process more efficient for our member sites.
Source: www.swog.orgCategories: General Medicine News, Onc News and JournalsTweet-
Our @SWOGChair blog: Data Capture with nCartes: A Leap Day Opportunity In our @SWOG-nCartes system, data from the electronic health record are automatically fed to the software, reviewed by study coordinators, then passed directly to case report forms. https://t.co/OadjAwmQPX https://t.co/h7V0CJZrgn
-
.@SWOG S2210 is now enrolling! Testing #neoadjuvant carboplatin in patients with high-risk localized #prostatecancer and a #BRCA1 or #BRCA2 germline mutation (per local lab). https://t.co/R38dZgdBuz #PCSM #urology PI: @heatherhcheng @FredHutch @UWMedicine @PCF_Science @PCaPROMISE https://t.co/pduAcXOxdX